The Venture Codex Logo

The Venture Codex

ATEM Capital

445 Park Ave Fl 23, New York, 10022, United States

Overview

Life Sciences investment fund focusing on BioPharma and MedTech.

Founded

2020

Deals · 12mo

0

Links

WebsiteLinkedIn

Stage focus

Series A
Series B
Series C

Geographic focus

France
United States

Sector focus

Biotechnology
Health Care

Investment portfolio

5rounds
NAMEDATESIZE
Deka Biosciences
Sep 2023Participated
$20 MSeries B
Amolyt Pharma
Jan 2023Participated
$137 MSeries C
Arpeggio Bio
Sep 2022Participated
$17 MSeries A
Amolyt Pharma
Sep 2021Participated
$80 MSeries B
Iridia
Mar 2021Participated
$24 MSeries B
Deka Biosciences
Sep 2023Participated
$20 MSeries B
Amolyt Pharma
Jan 2023Participated
$137 MSeries C
Arpeggio Bio
Sep 2022Participated
$17 MSeries A
Amolyt Pharma
Sep 2021Participated
$80 MSeries B
Iridia
Mar 2021Participated
$24 MSeries B
5
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

ATEM Capital: 5 funding rounds are recorded in the selected participation categories.All available history.
ATEM Capital: 5 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A01
Series B03
Series C+01

Monthly Deal Activity

ATEM Capital: 5 deals are recorded across 68 months.All available history.
ATEM Capital: 5 deals are recorded across 68 months. All available history
MonthDeals
Mar '211
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '211
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '221
Oct '220
Nov '220
Dec '220
Jan '231
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '231
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

ATEM Capital: Health & Life Sciences is the largest displayed sector by deal count (5 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

ATEM Capital: Health & Life Sciences is the largest displayed sector by deal count (5 deals). All available history
SectorDeals
Health & Life Sciences5
Hardware & Robotics1
Enterprise Software1
AI & Machine Learning1
Space & Frontier Tech1

Deal Size Distribution

ATEM Capital: 5 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

ATEM Capital: 5 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M3
$25M-$50M0
$50M-$100M1
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

ATEM Capital: United States has the largest recorded deal count among the displayed regions (3 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

ATEM Capital: United States has the largest recorded deal count among the displayed regions (3 deals). All available history
RegionDeals
United States3
Europe2
ATEM Capital: 20 co-investors are shown, with Andera Partners sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

ATEM Capital: 20 co-investors are shown, with Andera Partners sharing 2 recorded deals. All available history
Co-investorShared deals
Andera Partners2
Bpifrance2
Credit Agricole Creation2
EQT Life Sciences (LSP)2
Kurma Partners2
Mass General Brigham Ventures2
Novo Holdings2
OrbiMed2
Pontifax2
Sectoral Asset Management2
Alexandria Venture Investments1
Amana Investments1
Builders VC1
CTI Life Sciences Fund1
Eurazeo1
Fifty Years1
Formic Ventures1
FundersClub1
Intermediate Capital Group1
JSR Corporation1

Investment Strategy

ATEM Capital: Led accounts for 0% and participating for 100% of round participation.All available history.
ATEM Capital: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating5100%
ATEM Capital: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
ATEM Capital: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Allan Gobbs

CEO, Managing Partner